Pharmacokinetics and antidiuretic effect of a new vasopressin analogue (F992) in overhydrated male volunteers

European Journal of Clinical Pharmacology

Volumn 55, Issue 4, 1999, Pages 293-298

  Callreus T ^a   Hoglund P ^a   Lundahl, J ^b   Broeders, A ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Ferring Pharmaceuticals   (Sweden)

Author keywords

Antidiuresis; Vasopressin analogue F992 pharmacokinetics

Indexed keywords

F 992; UNCLASSIFIED DRUG; VASOPRESSIN DERIVATIVE;

ADULT; ANTIDIURESIS; ARTICLE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; DRUG POTENCY; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; HYDRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; DEPRESSION, CHEMICAL; DIURESIS; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; RENAL AGENTS; VASOPRESSINS;

EID: 0032915182     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050631     Document Type: Article

References (19)

1. 1. Vilhardt H (1990) Basic pharmacology of desmopressin. A review. Drug Invest 2: 2-8
2. 2. Cobb W, Pare S, Reichlin S (1978) Neurogenic diabetes insipidus: management with dDAVP (1-desamino-8-D arginine vasopressin). Ann Intern Med 88: 183-188
3. 3. Robinson A (1976) DDAVP in the treatment of central diabetes insipidus. New Engl J Med 294: 507-511
4. 4. Sukhai RN (1993) Enuresis nocturna: long term use and safety aspects of minrin (desmopressin) spray. Regul Pept 45: 309-310
5. 5. Matthiesen TB, Rittig S, Djurhuus JC, Norgaard JP (1994) A dose titration, and an open 6-week efficacy and safety study of desmopressin tablets in the management of nocturnal enuresis. J Urol 151: 460-463
6. 6. Rittig S, Knudsen UB, Norgaard JP, Pedersen EB, Djurhuus JC (1989) Abnormal diurnal rhythm of plasma vasopressin and urinary output in patients with enuresis. Am J Physiol 256: F664-F671
7. 7. d'Agay-Abensour L, Fjellestad-Paulsen A, Höglund P, Ngô Y, Paulsen O, Rambaud JC (1993), Absolute bioavailability of an aqueous solution of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract i man. Eur J Clin Pharmacol 44: 473-476
8. 8. Fjellestad-Paulsen A, Czernichow P (1986), Central diabetes insipidus in children. V. Oral treatment with a vasopressin hormone analogue (DDAVP). Acta Paediatr Scand 75: 605-610
9. 9. Hammer M, Vilhardt H (1985) Peroral treatment of diabetes insipidus with a polypeptide hormone analog, desmopressin. J Pharmacol Exp Ther 234: 754-760
10. 10. Robson WLM, Norgaard JP, Leung AKC (1996) Hyponatremia in patients with nocturnal enuresis treated with DDAVP. Eur J Pediatr 155: 959-962
11. 11. Callréus T, Höglund P (1998) Pharmacokinetics and antidiuretic effect of intravenous administration of desmopressin in orally overhydrated male volunteers. Pharmacol Toxicol 83: 259-262
12. 12. Tager HS (1976) Coupling of peptides to albumin with difluorodinitrobenzene. Anal Biochem 71: 367-375
13. 131I-labelled human growth hormone of high specific radioactivity. Biochem J 89: 114-123
14. 14. Vilhardt H, Lundin S, Falch J (1986) Plasma kinetics of DDAVP in man. Acta Pharmacol Toxicol 58: 379-381
15. 15. Fjellestad-Paulsen A, d'Agay-Abensour L, Höglund P, Rambaud J-C (1996) Bioavailability of 1-deamino-8-D-arginine vasopressin with an enzyme inhibitor (aprotinin) from the small intestine in healthy volunteers. Eur J Clin Pharmacol 50:491-495
16. 16. Williams T, Dunger D, Lyon C, Lewis R, Taylor F, Lightman S (1986) Antidiuretic effect and pharmacokinetics of oral 1-desamino-8-D-arginine vasopressin. 1. Studies in adults and children. J Clin Endocrinol Metab 63: 129-132
17. 17. Callréus T, Höglund P (1997) PK-PD modelling for urine osmolality following infusions with two different antidiuretic peptides in healthy male volunteers. Eur J Clin Pharmacol Suppl 52: A116
18. 18. Moses AM, Moses LK, Notman DD, Springer J (1981) Antidiuretic responses to injected desmopressin, alone and with indomethacin. J Clin Endocrinol Metab 52: 910-913
19. 19. Fjellestad-Paulsen A, Paulsen O, d'Agay-Abensour L, Lundin S, Czernichow P (1993) Central diabetes insipidus: oral treatment with dDAVP. Regul Pept 45: 303-307